Fri, 08 Mar 2024 14:58:15 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/cervical-cancer/simple-radical-hysterectomy-low-risk-cervical-cancer/ Fri, 08 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=117042 https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/ovarian-cancer-olaparib-bevacizumab-good-safety-profile-treatment/ Thu, 07 Mar 2024 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=117174 https://www.oncologynurseadvisor.com/home/cancer-types/gynecologic-cancer/pembrolizumab-plus-chemotherapy-under-review-for-primary-advanced-or-recurrent-endometrial-cancer/ Thu, 29 Feb 2024 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=116846 https://www.oncologynurseadvisor.com/home/cancer-types/cervical-cancer/dietary-magnesium-replacement-prevents-chemotherapy-treatment-risk/ Wed, 21 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116821 https://www.oncologynurseadvisor.com/home/cancer-types/gynecologic-cancer/metformin-endometrial-cancer-incidence-outcomes/ Wed, 14 Feb 2024 14:10:00 +0000 https://www.cancertherapyadvisor.com/?p=169314 https://www.oncologynurseadvisor.com/home/cancer-types/cervical-cancer/atezolizumab-plus-standard-care-improves-survival-in-advanced-cervical-cancer/ Thu, 11 Jan 2024 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115883 https://www.oncologynurseadvisor.com/home/cancer-types/gynecologic-cancer/cervical-cancer-dilation-sexual-activity-vaginal-stenosis-treatment-risk/ Thu, 12 Oct 2023 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=111311 Use of a dilator and/or engaging in sexual activity after treatment for cervical cancer reduced the risk of vaginal stenosis, but not vaginal dryness or bleeding.]]> https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/hipec-improves-long-term-outcomes-in-stage-iii-ovarian-cancer/ Mon, 02 Oct 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=110891 Adding HIPEC to interval cytoreductive surgery improves long-term outcomes in stage III epithelial ovarian cancer, a phase 3 trial suggests. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/ovarian-cancer-immune-checkpoint-inhibitor-lvef-rare-treatment-risk/ Thu, 28 Sep 2023 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=110987 Left ventricular ejection fraction data from the JAVELIN Ovarian 200 trial showed low cardiotoxicity in patients with ovarian cancer treated with avelumab, avelumab plus PLD, or PLD.]]> https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/screening-confers-small-survival-benefit-in-high-grade-serous-ovarian-cancer/ Fri, 15 Sep 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=110438 Screening can lead to earlier diagnosis of high-grade serous ovarian cancer, but this does not translate to a substantial improvement in survival, according to researchers.]]>